Related references
Note: Only part of the references are listed.CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma
Greg Parsonage et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Regulation of CXCL8/IL-8 Expression by Zonula Occludens-1 in Human Breast Cancer Cells
Anne Brysse et al.
MOLECULAR CANCER RESEARCH (2012)
Chemokines as mediators of tumor angiogenesis and neovascularization
Ellen C. Keeley et al.
EXPERIMENTAL CELL RESEARCH (2011)
CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation
Seema Singh et al.
MICROVASCULAR RESEARCH (2011)
Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer
Anne-Marie Baird et al.
PLOS ONE (2011)
Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis
Hector Alvarez et al.
PLOS GENETICS (2011)
Direct inhibition of human acute myeloid leukemia cell growth by IL-12
Elisa Ferretti et al.
IMMUNOLOGY LETTERS (2010)
Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum
M. Mueller et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis
A. Busuttil et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Chemokine-chemokine receptors in cancer immunotherapy
Trina J. Stewart et al.
IMMUNOTHERAPY (2009)
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
Xinrong Ma et al.
MOLECULAR CANCER THERAPEUTICS (2009)
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
Martin Augsten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chemokines as Mediators of Neovascularization
Ellen C. Keeley et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis
Sofie Struyf et al.
CANCER RESEARCH (2007)
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
Adi Zipin-Roitman et al.
CANCER RESEARCH (2007)
Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration
Manit Arya et al.
TUMOR BIOLOGY (2007)
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis
Jianhua Wang et al.
CANCER AND METASTASIS REVIEWS (2006)
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Jennifer M. Burns et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor
Svetlana M. Stamatovic et al.
JOURNAL OF IMMUNOLOGY (2006)
Epidermal growth factor receptor targeting in cancer
John Mendelsohn et al.
SEMINARS IN ONCOLOGY (2006)
Cancer CXC chemokine networks and tumour angiogenesis
RM Strieter et al.
EUROPEAN JOURNAL OF CANCER (2006)
Inflammatory chemokines in cancer growth and progression
BJ Rollins
EUROPEAN JOURNAL OF CANCER (2006)
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation
S Brand et al.
EXPERIMENTAL CELL RESEARCH (2005)
Modulation of CXCL14 (BRAK) expression in prostate cancer
SR Schwarze et al.
PROSTATE (2005)
Chemokines in tumor progression and metastasis
T Tanaka et al.
CANCER SCIENCE (2005)
Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8
R Schruefer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Interleukin-8 induces nuclear transcription factor-κB through a TRAF6-dependent pathway
SK Manna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer
MP Keane et al.
JOURNAL OF IMMUNOLOGY (2004)
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells
TD Shellenberger et al.
CANCER RESEARCH (2004)
Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping
JE Ehlert et al.
JOURNAL OF IMMUNOLOGY (2004)
Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis
CL Addison et al.
BMC CANCER (2004)
The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan
JM Yang et al.
MOLECULAR THERAPY (2004)
Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines
AP Vicari et al.
SEMINARS IN CANCER BIOLOGY (2004)
Platelet factor 4: An inhibitor of angiogenesis
A Bikfalvi
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
The significance of cancer cell expression of the chemokine receptor CXCR4
F Balkwill
SEMINARS IN CANCER BIOLOGY (2004)
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
K Kawada et al.
CANCER RESEARCH (2004)
Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis
S Struyf et al.
CIRCULATION RESEARCH (2004)
The chemokine network in cancer - much more than directing cell movement
H Kulbe et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-γ-dependent antitumor responses in a lung cancer model
S Hillinger et al.
JOURNAL OF IMMUNOLOGY (2003)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
JB Rubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Regulation of vascular development by fibroblast growth factors
P Auguste et al.
CELL AND TISSUE RESEARCH (2003)
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases
RJ Phillips et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
L Lasagni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2
J Heidemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Chemokine/chemokine receptor nomenclature
K Bacon et al.
CYTOKINE (2003)
Chemokines: key players in cancer
M Arya et al.
CURRENT MEDICAL RESEARCH AND OPINION (2003)
CXCRA is a major chemokine receptor on glioma cells and mediates their survival
Y Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors
YQ Liu et al.
CANCER GENE THERAPY (2002)
Chemokines in cancer
AP Vicari et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Chemokines: Agents for the immunotherapy of cancer?
B Homey et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity
K Palmer et al.
GENE THERAPY (2001)
Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity
P Romagnani et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells
J Kijowski et al.
STEM CELLS (2001)
The role of CXC chemokines in the regulation of tumor angiogenesis
S Dias et al.
CANCER INVESTIGATION (2001)
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
CL Addison et al.
JOURNAL OF IMMUNOLOGY (2000)
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells
R Salcedo et al.
FASEB JOURNAL (2000)
Autocrine growth effect of IL-8 and GROα on a human pancreatic cancer cell line, Capan-1
H Takamori et al.
PANCREAS (2000)
In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue
MJ Frederick et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-γ-Inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy
I Narvaiza et al.
JOURNAL OF IMMUNOLOGY (2000)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
The CXC chemokine, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis
CL Addison et al.
HUMAN GENE THERAPY (2000)
Share Paper
